Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/BAY_73-6691> ?p ?o }
Showing triples 1 to 81 of
81
with 100 triples per page.
- BAY_73-6691 abstract "BAY 73-6691 is a drug developed by Bayer for the treatment of Alzheimer's disease. It was the first compound developed that acts as a phosphodiesterase inhibitor selective for the PDE9A subtype. The PDE9A enzyme is expressed primarily in the brain, with high concentrations in the cerebellum, neocortex, striatum, and hippocampus, and acts to limit the cGMP-mediated signal transduction which occurs following glutamate binding to NMDA receptors. Consequently, selective PDE9A inhibitors were predicted to prolong intracellular responses to glutamate and enhance glutamate signalling, and since this process is known to be involved in learning and memory, PDE9A inhibitors should have a nootropic effect and may be useful in the treatment of Alzheimer's.Animal studies have confirmed these expectations, and BAY 73-6691 has been shown to improve learning and memory in rats. As the first selective PDE9A inhibitor to be developed, it is also widely used in research into the function of this enzyme subtype. However pre-clinical research is at an early stage and it is not yet known whether BAY 73-6691 will prove suitable to progress to human trials, or if it will remain merely a laboratory research tool.".
- BAY_73-6691 casNumber "794568-92-6".
- BAY_73-6691 iupacName "1-(2-chlorophenyl)-6-[(2R)-3,3,3-trifluoro-2-methylpropyl]-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidine-4-one".
- BAY_73-6691 pubchem "16078952".
- BAY_73-6691 thumbnail BAY73-6691_structure.png?width=300.
- BAY_73-6691 wikiPageID "20617726".
- BAY_73-6691 wikiPageLength "3889".
- BAY_73-6691 wikiPageOutDegree "18".
- BAY_73-6691 wikiPageRevisionID "689228467".
- BAY_73-6691 wikiPageWikiLink Alzheimers_disease.
- BAY_73-6691 wikiPageWikiLink Bayer.
- BAY_73-6691 wikiPageWikiLink Category:Chloroarenes.
- BAY_73-6691 wikiPageWikiLink Category:Lactams.
- BAY_73-6691 wikiPageWikiLink Category:Organofluorides.
- BAY_73-6691 wikiPageWikiLink Category:Phosphodiesterase_inhibitors.
- BAY_73-6691 wikiPageWikiLink Category:Pyrazolopyrimidines.
- BAY_73-6691 wikiPageWikiLink Cerebellum.
- BAY_73-6691 wikiPageWikiLink Cyclic_guanosine_monophosphate.
- BAY_73-6691 wikiPageWikiLink Glutamic_acid.
- BAY_73-6691 wikiPageWikiLink Hippocampus.
- BAY_73-6691 wikiPageWikiLink NMDA_receptor.
- BAY_73-6691 wikiPageWikiLink Neocortex.
- BAY_73-6691 wikiPageWikiLink Nootropic.
- BAY_73-6691 wikiPageWikiLink PDE9A.
- BAY_73-6691 wikiPageWikiLink Phosphodiesterase_inhibitor.
- BAY_73-6691 wikiPageWikiLink Signal_transduction.
- BAY_73-6691 wikiPageWikiLink Striatum.
- BAY_73-6691 wikiPageWikiLinkText "BAY 73-6691".
- BAY_73-6691 c "15".
- BAY_73-6691 casNumber "794568".
- BAY_73-6691 chembl "1513993".
- BAY_73-6691 chemspiderid "21171546".
- BAY_73-6691 cl "1".
- BAY_73-6691 f "3".
- BAY_73-6691 h "12".
- BAY_73-6691 inchi "1".
- BAY_73-6691 inchikey "FFPXPXOAFQCNBS-MRVPVSSYBD".
- BAY_73-6691 iupacName "1".
- BAY_73-6691 molecularWeight "356.73".
- BAY_73-6691 n "4".
- BAY_73-6691 o "1".
- BAY_73-6691 pubchem "16078952".
- BAY_73-6691 smiles "C[C@H]CF".
- BAY_73-6691 stdinchi "1".
- BAY_73-6691 stdinchikey "FFPXPXOAFQCNBS-MRVPVSSYSA-N".
- BAY_73-6691 verifiedrevid "461349234".
- BAY_73-6691 wikiPageUsesTemplate Template:Cascite.
- BAY_73-6691 wikiPageUsesTemplate Template:Chemspidercite.
- BAY_73-6691 wikiPageUsesTemplate Template:Drugbankcite.
- BAY_73-6691 wikiPageUsesTemplate Template:Drugbox.
- BAY_73-6691 wikiPageUsesTemplate Template:Phosphodiesterase_inhibitors.
- BAY_73-6691 wikiPageUsesTemplate Template:Stdinchicite.
- BAY_73-6691 subject Category:Chloroarenes.
- BAY_73-6691 subject Category:Lactams.
- BAY_73-6691 subject Category:Organofluorides.
- BAY_73-6691 subject Category:Phosphodiesterase_inhibitors.
- BAY_73-6691 subject Category:Pyrazolopyrimidines.
- BAY_73-6691 hypernym Drug.
- BAY_73-6691 type ChemicalSubstance.
- BAY_73-6691 type Drug.
- BAY_73-6691 type Amide.
- BAY_73-6691 type Heterocycle.
- BAY_73-6691 type Inhibitor.
- BAY_73-6691 type Lactam.
- BAY_73-6691 type Organofluoride.
- BAY_73-6691 type Organohalide.
- BAY_73-6691 type Organofluoride.
- BAY_73-6691 type Organohalide.
- BAY_73-6691 type ChemicalObject.
- BAY_73-6691 type Thing.
- BAY_73-6691 type Q8386.
- BAY_73-6691 comment "BAY 73-6691 is a drug developed by Bayer for the treatment of Alzheimer's disease. It was the first compound developed that acts as a phosphodiesterase inhibitor selective for the PDE9A subtype. The PDE9A enzyme is expressed primarily in the brain, with high concentrations in the cerebellum, neocortex, striatum, and hippocampus, and acts to limit the cGMP-mediated signal transduction which occurs following glutamate binding to NMDA receptors.".
- BAY_73-6691 label "BAY 73-6691".
- BAY_73-6691 sameAs Q4834702.
- BAY_73-6691 sameAs m.05202cz.
- BAY_73-6691 sameAs BAY_73-6691.
- BAY_73-6691 sameAs BAY_73-6691.
- BAY_73-6691 sameAs Q4834702.
- BAY_73-6691 wasDerivedFrom BAY_73-6691?oldid=689228467.
- BAY_73-6691 depiction BAY73-6691_structure.png.
- BAY_73-6691 isPrimaryTopicOf BAY_73-6691.